[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:cdkn2a-gene":3},{"name":4,"total":5,"recruiting":6,"trials":7},"CDKN2A Gene",18,17,[8,16,23,30,36,42,48,54,60,67,74,80,86,92,98,104,110,116],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT06623110","Phase II Study of RP2 as Immunoprevention in High-Risk Oral Precancerous Disease",[12],"Phase 2","RECRUITING","2026-08-26T02:16:32.589113Z","2026-05-05T02:43:28.883549Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT06357676","Glofitamab Plus Ibrutinib With Obinutuzumab for the Treatment of Patients With Mantle Cell Lymphoma, IGNITE MCL Trial",[20],"Phase 1\u002FPhase 2","2026-08-26T02:15:02.712396Z","2026-05-05T02:43:28.817702Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":28,"content_modified":29},"NCT04966481","Palbociclib and Cetuximab Versus Cetuximab Monotherapy for Patients With CDKN2A-altered, HPV-unrelated Head and Neck Squamous Cell Carcinoma Who Experienced Disease Progression on a PD-1\u002FL1 Inhibitor",[27],"Phase 3","2026-08-26T02:18:16.220328Z","2026-05-05T02:43:27.959921Z",{"nct_id":31,"title":32,"phases":33,"status":13,"updated_at":34,"content_modified":35},"NCT02523014","Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas",[12],"2026-08-26T02:16:38.897933Z","2026-05-05T02:43:27.482521Z",{"nct_id":37,"title":38,"phases":39,"status":13,"updated_at":40,"content_modified":41},"NCT05188508","Pembrolizumab, Olaparib, and Temozolomide for People With Glioma",[12],"2026-08-26T02:17:43.321968Z","2026-05-05T02:43:27.089223Z",{"nct_id":43,"title":44,"phases":45,"status":13,"updated_at":46,"content_modified":47},"NCT02896335","Palbociclib and Pembrolizumab In Central Nervous System Metastases",[12],"2026-08-26T02:18:38.865010Z","2026-07-24T01:27:14.926741Z",{"nct_id":49,"title":50,"phases":51,"status":13,"updated_at":52,"content_modified":53},"NCT05843253","Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant",[12],"2026-08-26T02:19:31.671303Z","2026-05-05T02:43:29.388169Z",{"nct_id":55,"title":56,"phases":57,"status":13,"updated_at":58,"content_modified":59},"NCT04040205","Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway Alteration",[12],"2026-08-26T02:18:07.037408Z","2026-05-05T02:43:28.417090Z",{"nct_id":61,"title":62,"phases":63,"status":13,"updated_at":65,"content_modified":66},"NCT06577987","Safety\u002FEfficacy Study of CID-078 in Patients With Advanced Solid Tumor Malignancies",[64],"Phase 1","2026-08-26T02:19:00.742020Z","2026-05-05T02:43:27.665400Z",{"nct_id":68,"title":69,"phases":70,"status":13,"updated_at":72,"content_modified":73},"NCT06122896","Prospective Screening for Pancreatic Ductal Adenocarcinoma in High-Risk Individuals",[71],"Early Phase 1","2026-08-26T02:17:13.277148Z","2026-05-05T02:43:27.075591Z",{"nct_id":75,"title":76,"phases":77,"status":13,"updated_at":78,"content_modified":79},"NCT02000089","The Cancer of the Pancreas Screening-5 CAPS5)Study",[27],"2026-08-26T02:17:20.511551Z","2026-05-05T02:43:27.641158Z",{"nct_id":81,"title":82,"phases":83,"status":13,"updated_at":84,"content_modified":85},"NCT07612046","A Study of Magnetic Resonance Imaging of the Pancreas for Cancer Screening",[],"2026-08-26T02:16:27.227548Z","2026-07-19T19:36:05.076756Z",{"nct_id":87,"title":88,"phases":89,"status":13,"updated_at":90,"content_modified":91},"NCT06271291","Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts",[],"2026-08-26T02:18:36.226508Z","2026-05-13T02:55:06.430707Z",{"nct_id":93,"title":94,"phases":95,"status":13,"updated_at":96,"content_modified":97},"NCT05006131","Pancreatic Cancer Screening for At-risk Individuals",[],"2026-08-26T02:17:12.307088Z","2026-05-13T02:55:06.277680Z",{"nct_id":99,"title":100,"phases":101,"status":13,"updated_at":102,"content_modified":103},"NCT03250078","A Pancreatic Cancer Screening Study in Hereditary High Risk Individuals",[],"2026-08-26T02:16:58.658552Z","2026-05-13T02:55:06.120432Z",{"nct_id":105,"title":106,"phases":107,"status":13,"updated_at":108,"content_modified":109},"NCT04970056","Pancreatic Cancer Early Detection Consortium",[],"2026-08-26T02:15:04.877798Z","2026-05-13T02:55:06.276618Z",{"nct_id":111,"title":112,"phases":113,"status":13,"updated_at":114,"content_modified":115},"NCT02775461","Pancreas Registry and High Risk Registry",[],"2026-08-26T02:15:27.567165Z","2026-05-13T02:55:06.101947Z",{"nct_id":117,"title":118,"phases":119,"status":120,"updated_at":121,"content_modified":122},"NCT07358208","Prospective Familial Registry for Pancreas Research",[],"ENROLLING_BY_INVITATION","2026-08-26T02:19:26.493949Z","2026-06-16T05:54:07.881076Z"]